Consolidated Financial Statements for the Third Quarter Ended December 31, 2019 FY2020 (April 1, 2019 – March 31, 2020)[UNAUDITED]

About Us Message from the president Corporate Data and Subsidiaries Corporate Executives Directions to Takara Bio Quality Assurance Policy Consolidated Subsidiaries Business Outline Bioindustry Gene Therapy News Release Investor Relstions Management Policy Financial Data IR Library Stock Information IR Calendar IR News Disclosure Policy FAQ Contact IR User Guide Products Site About Us Business Outline... Read more

Bruker Postpones Fourth Quarter 2019 Earnings Release and Webcast

BILLERICA, Mass.–(BUSINESS WIRE)– Bruker Corporation (Nasdaq: BRKR) today announced that it is postponing its fourth quarter and full year 2019 earnings results call to allow additional time to complete its year-end closing procedures, including procedures related to the effective income tax rate for 2019 and the related income tax balance sheet accounts. Bruker will issue... Read more

Luminex Corporation Reports Fourth Quarter and Full-Year 2019 Results

New Products and Effective Execution Support Return To Accelerated Organic Growth AUSTIN, Texas, Feb. 10, 2020 /PRNewswire/ — Luminex Corporation (Nasdaq: LMNX) today announced results for its fourth quarter and full-year ended December 31, 2019. All amounts in this release are in conformity with U.S. generally accepted accounting principles (“GAAP”). CURRENT HIGHLIGHTS Total revenue for the... Read more

Brooks Automation Reports Results of First Quarter of Fiscal 2020, Ended December 31, 2019, and Announces Quarterly Cash Dividend

Brooks Automation Reports Results of First Quarter of Fiscal 2020, Ended December 31, 2019, and Announces Quarterly Cash Dividend CHELMSFORD, Mass., Feb. 6, 2020 /PRNewswire/ — Brooks Automation, Inc. (Nasdaq: BRKS), a leader in automation solutions for the semiconductor manufacturing and life sciences industries, today reported financial results for the first fiscal quarter of 2020, ended... Read more

QIAGEN reports results for fourth quarter and full-year 2019

Delivers on Q4 2019 net sales outlook, exceeds on adjusted EPS Net sales of $413.5 million (+3% actual, +4% CER, vs. ~+3% CER outlook) Diluted EPS $0.19; adjusted EPS $0.48 ($0.48 CER, +20% CER vs. ~$0.45-0.46 CER outlook) Adjusted operating income margin rises to 33.5% of sales vs. 29.6% in Q4 2018 Achieves FY 2019... Read more

MTS Reports Fiscal 2020 First Quarter Financial Results

EDEN PRAIRIE, Minn., Feb. 3, 2020 /PRNewswire/ — MTS Systems Corporation (Nasdaq: MTSC), a leading global supplier of high-performance test systems, motion simulators and sensors, today reported financial results for its fiscal year 2020 first quarter ended December 28, 2019. FIRST QUARTER FINANCIAL AND OPERATING HIGHLIGHTS Revenue of $205.8 million, an increase of 1.3% Sensors revenue... Read more

Thermo Fisher Scientific Reports Fourth Quarter and Full Year 2019 Results

WALTHAM, Mass., Jan. 30, 2020 /PRNewswire/ — Thermo Fisher Scientific Inc. (NYSE: TMO), the world leader in serving science, today reported its financial results for the fourth quarter and full year ended December 31, 2019. Fourth Quarter and Full Year 2019 Highlights Fourth quarter revenue increased 5% to $6.83 billion. Fourth quarter GAAP diluted earnings per... Read more

Danaher Reports Fourth Quarter and Full Year 2019 Results

WASHINGTON, Jan. 30, 2020 /PRNewswire/ — Danaher Corporation (NYSE: DHR) (the “Company”) today announced results for the fourth quarter and full year 2019.  All results in this release reflect only continuing operations unless otherwise noted. For the quarter ended December 31, 2019, net earnings were $792.9 million, or $1.07 per diluted share which represents a... Read more